These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34900242)

  • 1. Targeting SARS-CoV-2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound.
    Eid JI; Das B; Al-Tuwaijri MM; Basal WT
    Food Sci Nutr; 2021 Dec; 9(12):6513-6523. PubMed ID: 34900242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoids.
    Amin FG; Elfiky AA; Nassar AM
    J Biomol Struct Dyn; 2024; 42(2):1079-1087. PubMed ID: 37042960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chaga Medicinal Mushroom Inonotus obliquus (Agaricomycetes) Terpenoids May Interfere with SARS-CoV-2 Spike Protein Recognition of the Host Cell: A Molecular Docking Study.
    Basal WT; Elfiky A; Eid J
    Int J Med Mushrooms; 2021; 23(3):1-14. PubMed ID: 33822495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach.
    Mathew SM; Benslimane F; Althani AA; Yassine HM
    Qatar Med J; 2021; 2021(1):12. PubMed ID: 34604010
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of defensins as neutralizing agents against the deadly SARS-CoV-2.
    Deepthi V; Mohanakumar KP; Rajamma U
    J Biomol Struct Dyn; 2023 Apr; 41(7):2911-2925. PubMed ID: 35189779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study.
    Mishra GP; Bhadane RN; Panigrahi D; Amawi HA; Asbhy CR; Tiwari AK
    Comput Biol Med; 2021 Jul; 134():104464. PubMed ID: 34020130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression.
    Bhullar KS; Nael MA; Elokely KM; Drews SJ; Wu J
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.
    Yang LJ; Chen RH; Hamdoun S; Coghi P; Ng JPL; Zhang DW; Guo X; Xia C; Law BYK; Wong VKW
    Phytomedicine; 2021 Jul; 87():153591. PubMed ID: 34029937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
    El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripeptides from Allium subhirsitum L. extracts: Pharmacokinetics properties, toxicity prediction and in silico study against SARS-CoV-2 enzymes and pro-inflammatory proteins.
    Snoussi M; Noumi E; Mosbah A; Redissi A; Saeed M; Tasleem M; Alreshidi M; Adnan M; Al-Rashidi A; Siddiqui AJ; Aouadi K; De Feo V; Kadri A
    Cell Mol Biol (Noisy-le-grand); 2022 Jan; 67(4):143-162. PubMed ID: 35809292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike.
    Kehinde IA; Egbeyemi A; Kaur M; Onyenaka C; Adebusuyi T; Olaleye OA
    J Biomol Struct Dyn; 2023 Apr; 41(7):2992-3001. PubMed ID: 35220925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective.
    Elshemey WM; Elfiky AA; Ibrahim IM; Elgohary AM
    Comput Biol Med; 2022 Jun; 145():105478. PubMed ID: 35421790
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Pandey AK; Verma S
    Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing immune boosting and anti-viral efficacy of
    Dinata R; Nisa N; Arati C; Rasmita B; Uditraj C; Siddhartha R; Bhanushree B; Saeed-Ahmed L; Manikandan B; Bidanchi RM; Abinash G; Pori B; Khushboo M; Roy VK; Gurusubramanian G
    J Biomol Struct Dyn; 2024; 42(1):43-81. PubMed ID: 37021347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetracycline as an inhibitor to the SARS-CoV-2.
    Zhao TY; Patankar NA
    J Cell Biochem; 2021 Jul; 122(7):752-759. PubMed ID: 33619758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
    Muhseen ZT; Hameed AR; Al-Hasani HMH; Ahmad S; Li G
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33525411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
    Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
    BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of honey bee pollen constituents against COVID-19: an emerging hot spot in targeting SARS-CoV-2-ACE-2 interaction.
    Zarei A; Ramazani A; Rezaei A; Moradi S
    Nat Prod Res; 2023 Mar; 37(6):974-980. PubMed ID: 35758279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation.
    Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP
    Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.